Lupus antibodies to the HMGB1 chromosomal protein: Epitope mapping and association with disease activity

Modern Rheumatology

Volumn 19, Issue 3, 2009, Pages 283-292

  Hayashi, Ayako ^a   Nagafuchi, Hiroko ^a   Ito, Ichiaki ^b   Hirota, Koichi ^a   Yoshida, Michiteru ^b   Ozaki, Shoichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Autoantibody; Epitope; High mobility group box 1 (HMGB1); Molecular mimicry; Systemic lupus erythematosus (SLE)

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; HIGH MOBILITY GROUP B2 PROTEIN; HIGH MOBILITY GROUP B2 PROTEIN ANTIBODY; METHYLPREDNISOLONE; PEPTIDE; PEPTIDE J; PREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT ONSET STILL DISEASE; ANTIBODY TITER; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; IMMUNOREACTIVITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

AUTOANTIBODIES; CASE-CONTROL STUDIES; EPITOPE MAPPING; HMGB1 PROTEIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR MIMICRY; SEVERITY OF ILLNESS INDEX;

EID: 67349282299     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0151-7     Document Type: Article

References (61)

1. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340-50.
2. Urbonaviciute V, Furnrohr BG, Weber C, Haslbeck M, Wilhelm S, Herrmann M, et al. Factors masking HMGB1 in human serum and plasma. J Leukoc Biol. 2007;81:67-74.
3. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta. 1990;1049:231-43.
4. Majumdar A, Brown D, Kerby S, Rudzinski I, Polte T, Randhawa Z, et al. Sequence of human HMG2 cDNA. Nucleic Acids Res. 1991;19:6643.
5. Wen L, Huang JK, Johnson BH, Reeck GR. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res. 1989;17:1197-214.
6. Shirakawa H, Yoshida M. Structure of a gene coding for human HMG2 protein. J Biol Chem. 1992;267:6641-5.
7. Shirakawa H, Tsuda K, Yoshida M. Primary structure of non-histone chromosomal protein HMG2 revealed by the nucleotide sequence. Biochemistry. 1990;29:4419-23.
8. Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, et al. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol. 1998;25:703-9.
9. Ayer LM, Rubin RL, Dixon GH, Fritzler MJ. Antibodies to HMG proteins in patients with drug-induced autoimmunity. Arthritis Rheum. 1994;37:98-103.
10. Neuer G, Bustin M, Michels H, Truckenbrodt H, Bautz FA. Autoantibodies to the chromosomal protein HMG-17 in juvenile rheumatoid arthritis. Arthritis Rheum. 1992;35:472-5.
11. Wittemann B, Neuer G, Michels H, Truckenbrodt H, Bautz FA. Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum. 1990;33:1378-83.
12. Burlingame RW, Rubin RL, Rosenberg AM. Autoantibodies to chromatin components in juvenile rheumatoid arthritis. Arthritis Rheum. 1993;36:836-41.
13. Ayer LM, Senecal JL, Martin L, Dixon GH, Fritzler MJ. Antibodies to high mobility group proteins in systemic sclerosis. J Rheumatol. 1994;21:2071-5.
14. Taira T, Matsuyama W, Mitsuyama H, Kawahara KI, Higashimoto I, Maruyama I, et al. Increased serum high mobility group box-1 level in Churg-Strauss syndrome. Clin Exp Immunol. 2007;148:241-7.
15. Ma W, Ozaki S, Sobajima J, Uesugi H, Murakami M, Tanaka M, et al. Detection of anti-neutrophil cytoplasmic antibodies in MRL/Mp-lpr/lpr mice and analysis of their target antigens. Autoimmunity. 2000;32:281-91.
16. Sobajima J, Ozaki S, Uesugi H, Osakada F, Inoue M, Fukuda Y, et al. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut. 1999;44:867-73.
17. Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M, et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: Non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol. 1997;107:135-40.
18. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-5.
19. Hunter P. Sepsis under siege: A new understanding of sepsis might lead to the development of therapies to treat septic shock. EMBO Rep. 2006;7:667-9.
20. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248-51.
21. Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, Susarla S, et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol. 2004;76:994-1001.
22. Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H, et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol. 2003;170:3890-7.
23. Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A, et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery. 1999;126:389-92.
24. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331-42.
25. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279:7370-7.
26. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res. 2002;62:4805-11.
27. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 2003;48:971-81.
28. Sanford AN, Dietzmann K, Sullivan KE. Apoptotic cells, autoantibodies, and the role of HMGB1 in the subcellular localization of an autoantigen. J Autoimmun. 2005;25:264-71.
29. Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M, et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum. 2005;52:3639-45.
30. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8:487-96.
31. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-7.
32. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol. 1991;18:1180-4.
33. Ulfgren AK, Grundtman C, Borg K, Alexanderson H, Andersson U, Harris HE, et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum. 2004;50:1586-94.
34. Adachi Y, Mizuno S, Yoshida M. Efficient large-scale purification of non-histone chromosomal proteins HMG1 and HMG2 by using Polybuffer-exchanger PBE94. J Chromatogr. 1990;530:39-46.
35. Ito I, Mitsuoka N, Sobajima J, Uesugi H, Ozaki S, Ohya K, et al. Conformational difference in HMGB1 proteins of human neutrophils and lymphocytes revealed by epitope mapping of a monoclonal antibody. J Biochem (Tokyo). 2004;136:155-62.
36. Kirkley JE, Goldstein AL, Naylor PH. Effect of peptide-carrier coupling on peptide-specific immune responses. Immunobiology. 2001;203:601-15.
37. Rose BG, Kamps-Holzapple C, Stanker LH. Competitive indirect ELISA for ceftiofur sodium and the effect of different immunizing and coating antigen conjugates. Bioconjug Chem. 1995;6:529-35.
38. Routsias JG, Tzioufas AG, Moutsopoulos HM. The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta. 2004;340:1-25.
39. Qing X, Pitashny M, Thomas DB, Barrat FJ, Hogarth MP, Putterman C. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: Involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett. 2008;121:61-73.
40. Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci USA. 1988;85:5186-9.
41. Chan EK, Tan EM. Epitopic targets for autoantibodies in systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol. 1989;1:376-81.
42. Dohlman JG, Lupas A, Carson M. Long charge-rich alpha-helices in systemic autoantigens. Biochem Biophys Res Commun. 1993;195:686-96.
43. Baxevanis AD, Landsman D. The HMG-1 box protein family: Classification and functional relationships. Nucleic Acids Res. 1995;23:1604-13.
44. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol. 2005;26:381-7.
45. Weir HM, Kraulis PJ, Hill CS, Raine AR, Laue ED, Thomas JO. Structure of the HMG box motif in the B-domain of HMG1. EMBO J. 1993;12:1311-9.
46. van Venrooij WJ, van Gelder CW. B cell epitopes on nuclear autoantigens. What can they tell us? Arthritis Rheum. 1994;37:608-16.
47. Scannell DR, Frank AC, Conant GC, Byrne KP, Woolfit M, Wolfe KH. Independent sorting-out of thousands of duplicated gene pairs in two yeast species descended from a whole-genome duplication. Proc Natl Acad Sci USA. 2007;104:8397-402.
48. Krause A, Ramakumar A, Bartels D, Battistoni F, Bekel T, Boch J, et al. Complete genome of the mutualistic, N 2 -fixing grass endophyte Azoarcus sp. strain BH72. Nat Biotechnol. 2006;24:1385-91.
49. Chen XH, Koumoutsi A, Scholz R, Eisenreich A, Schneider K, Heinemeyer I, et al. Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42. Nat Biotechnol. 2007;25:1007-14.
50. Dietrich FS, Voegeli S, Brachat S, Lerch A, Gates K, Steiner S, et al. The Ashbya gossypii genome as a tool for mapping the ancient Saccharomyces cerevisiae genome. Science. 2004;304:304-7.
51. Bruggemann H, Baumer S, Fricke WF, Wiezer A, Liesegang H, Decker I, et al. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci USA. 2003;100:1316-21.
52. Matsunaga T, Okamura Y, Fukuda Y, Wahyudi AT, Murase Y, Takeyama H. Complete genome sequence of the facultative anaerobic magnetotactic bacterium Magnetospirillum sp. strain AMB-1. DNA Res. 2005;12:157-66.
53. Shirai T, Suzuki A, Yamane T, Ashida T, Kobayashi T, Hitomi J, et al. High-resolution crystal structure of M-protease: Phylogeny aided analysis of the high-alkaline adaptation mechanism. Protein Eng. 1997;10:627-34.
54. Dujon B, Sherman D, Fischer G, Durrens P, Casaregola S, Lafontaine I, et al. Genome evolution in yeasts. Nature. 2004;430:35-44.
55. Caldwell RB, Kierzek AM, Arakawa H, Bezzubov Y, Zaim J, Fiedler P, et al. Full-length cDNAs from chicken bursal lymphocytes to facilitate gene function analysis. Genome Biol. 2005;6:R6.
56. Pohlmann A, Fricke WF, Reinecke F, Kusian B, Liesegang H, Cramm R, et al. Genome sequence of the bioplastic-producing "Knallgas" bacterium Ralstonia eutropha H16. Nat Biotechnol. 2006;24:1257-62.
57. Joardar V, Lindeberg M, Jackson RW, Selengut J, Dodson R, Brinkac LM, et al. Whole-genome sequence analysis of Pseudomonas syringae pv. phaseolicola 1448A reveals divergence among pathovars in genes involved in virulence and transposition. J Bacteriol. 2005;187:6488-98.
58. Yu J, Wang J, Lin W, Li S, Li H, Zhou J, et al. The genomes of Oryza sativa: A history of duplications. PLoS Biol. 2005;3:e38.
59. Zhang YQ, Ren SX, Li HL, Wang YX, Fu G, Yang J, et al. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol. 2003;49:1577-93.
60. von Landenberg P, Lehmann HW, Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev. 2007;6:278-85.
61. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005;11:85-9.